These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 1407890)
1. Determinants of survival of surgically staged patients with endometrial carcinoma histologically confined to the uterus: implications for therapy. Kadar N; Malfetano JH; Homesley HD Obstet Gynecol; 1992 Oct; 80(4):655-9. PubMed ID: 1407890 [TBL] [Abstract][Full Text] [Related]
2. The significance of the amount of myometrial invasion in patients with Stage IB endometrial carcinoma. Alektiar KM; McKee A; Lin O; Venkatraman E; Zelefsky MJ; Mychalczak BR; McKee B; Hoskins WJ; Barakat RR Cancer; 2002 Jul; 95(2):316-21. PubMed ID: 12124832 [TBL] [Abstract][Full Text] [Related]
3. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma. Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL Gynecol Oncol; 2000 Apr; 77(1):55-65. PubMed ID: 10739691 [TBL] [Abstract][Full Text] [Related]
4. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation. Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441 [TBL] [Abstract][Full Text] [Related]
5. [Multivariate analysis of prognostic factors in endometrial carcinoma]. Li B; Wu LY; Li SM; Zhang WH; Zhang R; Ma SK Ai Zheng; 2004 Sep; 23(9):1085-8. PubMed ID: 15363208 [TBL] [Abstract][Full Text] [Related]
6. Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion. Orezzoli JP; Sioletic S; Olawaiye A; Oliva E; del Carmen MG Gynecol Oncol; 2009 Jun; 113(3):316-23. PubMed ID: 19345400 [TBL] [Abstract][Full Text] [Related]
7. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology. Lutman CV; Havrilesky LJ; Cragun JM; Secord AA; Calingaert B; Berchuck A; Clarke-Pearson DL; Soper JT Gynecol Oncol; 2006 Jul; 102(1):92-7. PubMed ID: 16406063 [TBL] [Abstract][Full Text] [Related]
8. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer. Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407 [TBL] [Abstract][Full Text] [Related]
11. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer. Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137 [TBL] [Abstract][Full Text] [Related]
12. Analysis of FIGO Stage IIIc endometrial cancer patients. McMeekin DS; Lashbrook D; Gold M; Johnson G; Walker JL; Mannel R Gynecol Oncol; 2001 May; 81(2):273-8. PubMed ID: 11330962 [TBL] [Abstract][Full Text] [Related]
13. Para-aortic lymphadenectomy improves survival in patients with intermediate to high-risk endometrial carcinoma. Chang SJ; Kim WY; Yoon JH; Yoo SC; Chang KH; Ryu HS Acta Obstet Gynecol Scand; 2008; 87(12):1361-9. PubMed ID: 18951214 [TBL] [Abstract][Full Text] [Related]
14. Adjuvant chemotherapy as treatment of high-risk stage I and II endometrial cancer. Aoki Y; Watanabe M; Amikura T; Obata H; Sekine M; Yahata T; Fujita K; Tanaka K Gynecol Oncol; 2004 Aug; 94(2):333-9. PubMed ID: 15297170 [TBL] [Abstract][Full Text] [Related]
15. Management of aggressive histologic variants of endometrial carcinoma at the Tom Baker Cancer Centre between 1984 and 1994. Craighead PS; Sait K; Stuart GC; Arthur K; Nation J; Duggan M; Guo D Gynecol Oncol; 2000 May; 77(2):248-53. PubMed ID: 10785473 [TBL] [Abstract][Full Text] [Related]
16. Prospective evaluation of prognostic significance of the tumor-free distance from uterine serosa in surgically staged endometrial adenocarcinoma. Schwab KV; O'Malley DM; Fowler JM; Copeland LJ; Cohn DE Gynecol Oncol; 2009 Jan; 112(1):146-9. PubMed ID: 18937970 [TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of serous and clear cell adenocarcinoma in surgically staged endometrial carcinoma. Sakuragi N; Hareyama H; Todo Y; Yamada H; Yamamoto R; Fujino T; Sagawa T; Fujimoto S Acta Obstet Gynecol Scand; 2000 Apr; 79(4):311-6. PubMed ID: 10746848 [TBL] [Abstract][Full Text] [Related]
18. FIGO stage IIIC endometrial carcinoma with metastases confined to pelvic lymph nodes: analysis of treatment outcomes, prognostic variables, and failure patterns following adjuvant radiation therapy. Nelson G; Randall M; Sutton G; Moore D; Hurteau J; Look K Gynecol Oncol; 1999 Nov; 75(2):211-4. PubMed ID: 10525373 [TBL] [Abstract][Full Text] [Related]
19. Good outcome associated with a standardized treatment protocol using selective postoperative radiation in patients with clinical stage I adenocarcinoma of the endometrium. Carey MS; O'Connell GJ; Johanson CR; Goodyear MD; Murphy KJ; Daya DM; Schepansky A; Peloquin A; Lumsden BJ Gynecol Oncol; 1995 May; 57(2):138-44. PubMed ID: 7729725 [TBL] [Abstract][Full Text] [Related]
20. Survival of women with surgical stage II endometrial cancer. Eltabbakh GH; Moore AD Gynecol Oncol; 1999 Jul; 74(1):80-5. PubMed ID: 10385555 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]